Literature DB >> 6327494

Widespread presence of histologically occult cytomegalovirus.

D Myerson, R C Hackman, J A Nelson, D C Ward, J K McDougall.   

Abstract

Disseminated cytomegalovirus (CMV) has been investigated by in situ hybridization in formalin-fixed paraffin-embedded tissue sections with biotinylated DNA probes. Two cases of disseminated CMV infection were studied at autopsy by this highly specific technique. The presence of CMV in cytomegalic cells is readily shown. In addition, CMV has been detected and localized in many normal-appearing cells. This occult infection occurs in cardiac myocytes, hepatocytes, spleen and lymph node reticular cells, endometrial stromal and glandular cells, and breast stromal cells, as well as in cells in the renal glomerulus, tubule, and interstitium, adrenal cortex and medulla, fallopian tube submucosa, myometrium, and anterior pituitary. Cytomegalovirus infection of endothelial cells has been further documented by immunohistochemical methods utilizing antibody to Factor VIII. These findings suggest that CMV disseminates hematogenously throughout the body, initiating necrotizing foci of infection. The appearance of many diffuse foci suggests that local viral spread occurs via endothelial cell infection. Surprisingly , lymphocyte involvement was not observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327494     DOI: 10.1016/s0046-8177(84)80076-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  108 in total

1.  DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction.

Authors:  H S Debinski; M A Kamm; I C Talbot; G Khan; H O Kangro; D J Jeffries
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

Review 3.  Diagnosis of cytomegalovirus infection: a review.

Authors:  D Pillay; P D Griffiths
Journal:  Genitourin Med       Date:  1992-06

Review 4.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

5.  Multiple ulcers of the ileum due to Cytomegalovirus infection in a patient who showed no evidence of an immunocompromised state.

Authors:  S Taniwaki; M Kataoka; H Tanaka; Y Mizuno; M Hirose
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

6.  [Diagnosis and clinical aspects of gastrointestinal cytomegalovirus diseases in patients with human immunodeficiency virus 1 infection].

Authors:  M Schrappe-Bächer; H M Steffen; G Ollenschläger; B Salzberger; G Fätkenheuer; S Degenhardt; G R Krüger
Journal:  Klin Wochenschr       Date:  1989-11-03

7.  Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

Authors:  N D Francis; A W Boylston; A H Roberts; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

8.  Severe neuropathy in a patient with acquired immune deficiency syndrome (AIDS). Evidence for widespread cytomegalovirus infection of peripheral nerve and human immunodeficiency virus-like immunoreactivity of anterior horn cells.

Authors:  M E Robert; J J Geraghty; S A Miles; M E Cornford; H V Vinters
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.